Updated LIST OF NEW DRUG APPROVED FROM 01-01-2016 to till 30th September

S.No

Name Of Drug

Indication

Date of issue

1

Nintedanib soft Gelatin Capsule 100/150mg

For the treatment of Idiopathic Pulmonary Fibrosis (IPF).

11.03.16

2

Cisatracurium Besylate Bulk & 2mg/ml injection

As an adjunct to general anaesthesia, to facilitate tracheal intubation and to provide skeletal muscle relaxation during surgery.

 

14.03.16

3

Fomepizole Bulk &1.5gm/Ampoule

As an antidote for Ethylene glycol or Methanol used poisoning or for use in suspected Ethylene glycol or Methanol ingestion, either alone or in combination with hemodialysis.

 

14.03.16

4

Tofacitinib Tablets 5 mg

“For the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to Methotrexate. It may be used as monotherapy or in combination with methotrexate or other nonbiologic disease-modifying antirheumatic drugs (DMARDs)”.

 

01.04.16

5

Nintedanib Soft Gelatin Capsule 100/150mg (Nintedanib ethanesulfonate)

"In combination with docetaxel for the treatment of adult patients with locally advanced, metastatic or recurrent non-small cell lung cancer (NSCLC) of adenocarcinoma tumor histology after line chemotherapy".

01.04.16

6

Ceftaroline Fosamil Injection 600 mg/Vial

"For the treatment of adult (≥ 18 years of age patients with community-acquired pneumonia".

 

09.05.2016

7

Panobinostat Hard Gelatin Capsules 10mg/15mg/20mg (Panobinostat lactate)

"In combination with bortezomib and dexamethasone, is indicated for the treatment of patients with multiple myeloma, who have received at least 1 prior therapy"

     27.05.2016

8

Bepotastine Besilate Bulk &

Bepotastine Besilate 1.5 %w/v

Ophthalmic solution

 

“For the treatment of itching associated with allergic conjunctivitis”

 

08.06.16

9

Ibutilide Bulk &

Ibutilide Fumarate Injection

0.1mg/ml

 

"For the rapid conversion of atrial fibrillation or atrial flutter of recent onset to sinus rhythm. Patient with atrial arrhythmias of longer duration are less likely to respond to Ibutilide Fumarate Injection. The effectiveness of Ibutilidehas not been determined in patients with arrhythmias of more than 90 days in duration”.

 

10.06.16

10

Acotiamide Hydrochloride Bulk & Tablet 100mg

"For the treatment of bloating after meals, epigastric bloating and early satiety in functional dyspepsia".

06.07.2016

11

Sacubutril+ Valsartan film coated tablets 50mg/100 mg/200mg

"To reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction".

14.07.2016

12

Lurasidone Hydrochloride Bulk & Lurasidone Hydrochloride Tablets 40mg/80mg

"For the treatment of Patients with Schizophrenia"           

18.07.16

13

Fenticonazole Nitrate Vaginal Capsule 600 mg 

"For the treatment of vulvovaginal candidiasis"

10.08.2016

14

Palbociclib Capsules 75mg/100mg/125 mg

"Palbociclib is a kinase inhibitor indicated in combination with Letrozole for the treatment of postmenopausal women with estrogen receptor (ER)-Positive, human epidermal growth factor receptor 2 (HER2)-Negative advanced breast cancer as initial endocrine-based therapy for their metastatic disease".

11.08.2016

15

Midodrine Hydrochloride 2.5 mg Tablet

"For the treatment of symptomatic orthostatic hypotension"

02.09.2016

16

Phospholipids Fraction from Bovine Lung (surfactant) 50 mg/vial

"Preventive use in premature neonates with a high risk of respiratory Distress Syndrome"

12.09.2016

 

CDSCO

 

FDA Approves Invokamet XR

FDA Approves Invokamet XR (Canagliflozin/Metformin Hydrochloride Extended-Release) for the Treatment of Adults with Type 2 Diabetes

 

FDA Approves Neratinib

Puma Biotechnology Announces FDA Acceptance of NDA for PB272 (Neratinib) for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer

 

FDA Approves Yosprala

FDA Approves Yosprala (aspirin and omeprazole) for Secondary Prevention of Cardiovascular Disease in Patients at Risk for Aspirin-Associated Gastric Ulcers.